160 related articles for article (PubMed ID: 38379304)
21. A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors.
Ho YP; Schnabel V; Swiersy A; Stirnnagel K; Lindemann D
Mol Ther; 2012 Jun; 20(6):1167-76. PubMed ID: 22472951
[TBL] [Abstract][Full Text] [Related]
22. Woodchuck hepatitis virus post-transcriptional regulation element enhances transgene expression from adenovirus vectors.
Xu ZL; Mizuguchi H; Mayumi T; Hayakawa T
Biochim Biophys Acta; 2003 Jun; 1621(3):266-71. PubMed ID: 12787924
[TBL] [Abstract][Full Text] [Related]
23. Antiviral role of IFITM3 in prototype foamy virus infection.
Wang Z; Tuo X; Zhang J; Chai K; Tan J; Qiao W
Virol J; 2022 Nov; 19(1):195. PubMed ID: 36419065
[TBL] [Abstract][Full Text] [Related]
24. Delivery of large transgene cassettes by foamy virus vector.
Sweeney NP; Meng J; Patterson H; Morgan JE; McClure M
Sci Rep; 2017 Aug; 7(1):8085. PubMed ID: 28808269
[TBL] [Abstract][Full Text] [Related]
25. Foamy Virus Integrase in Development of Viral Vector for Gene Therapy.
Kim J; Lee GE; Shin CG
J Microbiol Biotechnol; 2020 Sep; 30(9):1273-1281. PubMed ID: 32699199
[TBL] [Abstract][Full Text] [Related]
26. WPRE-mediated enhancement of gene expression is promoter and cell line specific.
Klein R; Ruttkowski B; Knapp E; Salmons B; Günzburg WH; Hohenadl C
Gene; 2006 May; 372():153-61. PubMed ID: 16488559
[TBL] [Abstract][Full Text] [Related]
27. PREB inhibits the replication of prototype foamy virus by affecting its transcription.
Zhang J; Xu Y; Wang C; Tuo X; Zhao X; Qiao W; Tan J
Virol J; 2023 Oct; 20(1):244. PubMed ID: 37885034
[TBL] [Abstract][Full Text] [Related]
28. Efficient production of inhibitor-free foamy virus glycoprotein-containing retroviral vectors by proteoglycan-deficient packaging cells.
Munz CM; Kreher H; Erdbeer A; Richter S; Westphal D; Yi B; Behrendt R; Stanke N; Lindel F; Lindemann D
Mol Ther Methods Clin Dev; 2022 Sep; 26():394-412. PubMed ID: 36034773
[TBL] [Abstract][Full Text] [Related]
29. The
Ma Y; Wei J; Song J; Hu Z; Zhang R; Li Z; Sun Y
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766305
[TBL] [Abstract][Full Text] [Related]
30. Foamy virus vectors.
Mergia A; Heinkelein M
Curr Top Microbiol Immunol; 2003; 277():131-59. PubMed ID: 12908771
[TBL] [Abstract][Full Text] [Related]
31. Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy.
Loeb JE; Cordier WS; Harris ME; Weitzman MD; Hope TJ
Hum Gene Ther; 1999 Sep; 10(14):2295-305. PubMed ID: 10515449
[TBL] [Abstract][Full Text] [Related]
32. Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer.
Hamann MV; Stanke N; Müllers E; Stirnnagel K; Hütter S; Artegiani B; Bragado Alonso S; Calegari F; Lindemann D
Mol Ther; 2014 Aug; 22(8):1460-1471. PubMed ID: 24814152
[TBL] [Abstract][Full Text] [Related]
33. Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS.
Zanta-Boussif MA; Charrier S; Brice-Ouzet A; Martin S; Opolon P; Thrasher AJ; Hope TJ; Galy A
Gene Ther; 2009 May; 16(5):605-19. PubMed ID: 19262615
[TBL] [Abstract][Full Text] [Related]
34. Cryo-electron Microscopy Structure of the Native Prototype Foamy Virus Glycoprotein and Virus Architecture.
Effantin G; Estrozi LF; Aschman N; Renesto P; Stanke N; Lindemann D; Schoehn G; Weissenhorn W
PLoS Pathog; 2016 Jul; 12(7):e1005721. PubMed ID: 27399201
[TBL] [Abstract][Full Text] [Related]
35. Increased utility in the CNS of a powerful neuron-specific tetracycline-regulatable adenoviral system developed using a post-transcriptional enhancer.
Lee YB; Cosgrave AS; Glover CP; Bienemann A; Heywood D; Hobson RJ; Uney JB
J Gene Med; 2005 May; 7(5):576-83. PubMed ID: 15580589
[TBL] [Abstract][Full Text] [Related]
36. Increased in vitro and in vivo transgene expression levels mediated through cis-acting elements.
Johansen J; Tornøe J; Møller A; Johansen TE
J Gene Med; 2003 Dec; 5(12):1080-9. PubMed ID: 14661183
[TBL] [Abstract][Full Text] [Related]
37. The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors.
Higashimoto T; Urbinati F; Perumbeti A; Jiang G; Zarzuela A; Chang LJ; Kohn DB; Malik P
Gene Ther; 2007 Sep; 14(17):1298-304. PubMed ID: 17597793
[TBL] [Abstract][Full Text] [Related]
38. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors.
Russell RA; Wiegand HL; Moore MD; Schäfer A; McClure MO; Cullen BR
J Virol; 2005 Jul; 79(14):8724-31. PubMed ID: 15994766
[TBL] [Abstract][Full Text] [Related]
39. Subviral particle release determinants of prototype foamy virus.
Stange A; Lüftenegger D; Reh J; Weissenhorn W; Lindemann D
J Virol; 2008 Oct; 82(20):9858-69. PubMed ID: 18684814
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs.
Park J; Nadeau P; Zucali JR; Johnson CM; Mergia A
Virology; 2005 Dec; 343(2):275-82. PubMed ID: 16181654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
